Technology
Health
Biotechnology
Kazia Therapeutics
$3.609876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.19 (-4.98%) Today
-$0.19 (-4.98%) Today
Why Robinhood?
You can buy or sell KZIA and other stocks, options, ETFs, and crypto commission-free!
About
Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. Read More The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
CEO
Employees
—
Headquarters
Sydney, New South Wales (NSW)
Founded
1994
Market Cap
23.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.79K
High Today
$3.80
Low Today
$3.60
Open Price
$3.80
Volume
3.94K
52 Week High
$6.19
52 Week Low
$2.04
Collections
Technology
Health
Biotechnology
Therapy
Pharmaceutical
Cancer Prevention
News
Simply Wall StFeb 20
Is Kazia Therapeutics Limited’s (ASX:KZA) CEO Pay Fair?
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! James Garner has been the CEO of Kazia Therapeutics Limited (ASX:KZA) since 2016. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Then we’ll look at a snap shot of the business growth. Third, we’ll reflect on the total return to shareholders over three years, as a second measure of business performance. The aim of all this is to...
Price Paid on Robinhood
41% Lower
Right Now
52 Week Low
$2.04
Average Price Paid
$6.09
52 Week High
$6.19